Literature DB >> 21427410

Increased energy expenditure and leptin sensitivity account for low fat mass in myostatin-deficient mice.

Sun Ju Choi1, Zipora Yablonka-Reuveni, Karl J Kaiyala, Kayoko Ogimoto, Michael W Schwartz, Brent E Wisse.   

Abstract

Myostatin deficiency causes dramatically increased skeletal muscle mass and reduced fat mass. Previously, myostatin-deficient mice were reported to have unexpectedly low total energy expenditure (EE) after normalizing to body mass, and thus, a metabolic cause for low fat mass was discounted. To clarify how myostatin deficiency affects the control of body fat mass and energy balance, we compared rates of oxygen consumption, body composition, and food intake in young myostatin-deficient mice relative to wild-type (WT) and heterozygous (HET) controls. We report that after adjusting for total body mass using regression analysis, young myostatin-deficient mice display significantly increased EE relative to both WT (+0.81 ± 0.28 kcal/day, P = 0.004) and HET controls (+0.92 ± 0.31 kcal/day, P = 0.005). Since food intake was not different between groups, increased EE likely accounts for the reduced body fat mass (KO: 8.8 ± 1.1% vs. WT: 14.5 ± 1.3%, P = 0.003) and circulating leptin levels (KO: 0.7 ± 0.2 ng/ml vs. WT: 1.9 ± 0.3 ng/ml, P = 0.008). Interestingly, the observed increase in adjusted EE in myostatin-deficient mice occurred despite dramatically reduced ambulatory activity levels (-50% vs. WT, P < 0.05). The absence of hyperphagia together with increased EE in myostatin-deficient mice suggests that increased leptin sensitivity may contribute to their lean phenotype. Indeed, leptin-induced anorexia (KO: -17 ± 1.2% vs. WT: -5 ± 0.3%) and weight loss (KO: -2.2 ± 0.2 g vs. WT: -1.6 ± 0.1, P < 0.05) were increased in myostatin-deficient mice compared with WT controls. We conclude that increased EE, together with increased leptin sensitivity, contributes to low fat mass in mice lacking myostatin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21427410      PMCID: PMC3118591          DOI: 10.1152/ajpendo.00656.2010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  38 in total

Review 1.  Neuroendocrine mechanisms regulating food intake and body weight.

Authors:  J E McMinn; D G Baskin; M W Schwartz
Journal:  Obes Rev       Date:  2000-05       Impact factor: 9.213

2.  Myostatin mutation associated with gross muscle hypertrophy in a child.

Authors:  Markus Schuelke; Kathryn R Wagner; Leslie E Stolz; Christoph Hübner; Thomas Riebel; Wolfgang Kömen; Thomas Braun; James F Tobin; Se-Jin Lee
Journal:  N Engl J Med       Date:  2004-06-24       Impact factor: 91.245

3.  Fallacy of per-weight and per-surface area standards, and their relation to spurious correlation.

Authors:  J M TANNER
Journal:  J Appl Physiol       Date:  1949-07       Impact factor: 3.531

4.  Myostatin knockout in mice increases myogenesis and decreases adipogenesis.

Authors:  Ji Lin; Heather B Arnold; Mary Anne Della-Fera; Michael J Azain; Diane L Hartzell; Clifton A Baile
Journal:  Biochem Biophys Res Commun       Date:  2002-03-01       Impact factor: 3.575

5.  Suppression of body fat accumulation in myostatin-deficient mice.

Authors:  Alexandra C McPherron; Se-Jin Lee
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

6.  PTP1B regulates leptin signal transduction in vivo.

Authors:  Janice M Zabolotny; Kendra K Bence-Hanulec; Alain Stricker-Krongrad; Fawaz Haj; Yongping Wang; Yasuhiko Minokoshi; Young-Bum Kim; Joel K Elmquist; Louis A Tartaglia; Barbara B Kahn; Benjamin G Neel
Journal:  Dev Cell       Date:  2002-04       Impact factor: 12.270

7.  Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2.

Authors:  L Abu-Elheiga; M M Matzuk; K A Abo-Hashema; S J Wakil
Journal:  Science       Date:  2001-03-30       Impact factor: 47.728

Review 8.  Signaling pathways weigh in on decisions to make or break skeletal muscle.

Authors:  Denis C Guttridge
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2004-07       Impact factor: 4.294

9.  Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis.

Authors:  Gersh Z Taicher; Frank C Tinsley; Arcady Reiderman; Mark L Heiman
Journal:  Anal Bioanal Chem       Date:  2003-09-16       Impact factor: 4.142

10.  Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis.

Authors:  Frank C Tinsley; Gersh Z Taicher; Mark L Heiman
Journal:  Obes Res       Date:  2004-01
View more
  17 in total

1.  Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice.

Authors:  C Zhang; C McFarlane; S Lokireddy; S Masuda; X Ge; P D Gluckman; M Sharma; R Kambadur
Journal:  Diabetologia       Date:  2011-09-17       Impact factor: 10.122

2.  Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice.

Authors:  João-Paulo G Camporez; Max C Petersen; Abulizi Abudukadier; Gabriela V Moreira; Michael J Jurczak; Glenn Friedman; Christopher M Haqq; Kitt Falk Petersen; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

3.  Leptin treatment reduces body fat but does not affect lean body mass or the myostatin-follistatin-activin axis in lean hypoleptinemic women.

Authors:  Mary Brinkoetter; Faidon Magkos; Maria Vamvini; Christos S Mantzoros
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-04-19       Impact factor: 4.310

Review 4.  The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials.

Authors:  L A Consitt; B C Clark
Journal:  J Frailty Aging       Date:  2018

5.  Increasing muscle mass to improve metabolism.

Authors:  Alexandra C McPherron; Tingqing Guo; Nichole D Bond; Oksana Gavrilova
Journal:  Adipocyte       Date:  2013-04-01       Impact factor: 4.534

6.  Subcongenic analysis of tabw2 obesity QTL on mouse chromosome 6.

Authors:  Taryn P Stewart; Xia Mao; Maha N Aqqad; Deon Uffort; Kristy D Dillon; Arnold M Saxton; Jung Han Kim
Journal:  BMC Genet       Date:  2012-10-01       Impact factor: 2.797

7.  Targeted loss of GHR signaling in mouse skeletal muscle protects against high-fat diet-induced metabolic deterioration.

Authors:  Archana Vijayakumar; YingJie Wu; Hui Sun; Xiaosong Li; Zuha Jeddy; Chengyu Liu; Gary J Schwartz; Shoshana Yakar; Derek LeRoith
Journal:  Diabetes       Date:  2012-01       Impact factor: 9.461

Review 8.  Connecting Myokines and Metabolism.

Authors:  Rexford S Ahima; Hyeong Kyu Park
Journal:  Endocrinol Metab (Seoul)       Date:  2015-08-04

9.  Association of the Myostatin gene with obesity, abdominal obesity and low lean body mass and in non-diabetic Asian Indians in north India.

Authors:  Surya Prakash Bhatt; Priyanka Nigam; Anoop Misra; Randeep Guleria; Kalpana Luthra; S K Jain; M A Qadar Pasha
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

10.  Adult onset global loss of the fto gene alters body composition and metabolism in the mouse.

Authors:  Fiona McMurray; Chris D Church; Rachel Larder; George Nicholson; Sara Wells; Lydia Teboul; Y C Loraine Tung; Debra Rimmington; Fatima Bosch; Veronica Jimenez; Giles S H Yeo; Stephen O'Rahilly; Frances M Ashcroft; Anthony P Coll; Roger D Cox
Journal:  PLoS Genet       Date:  2013-01-03       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.